Skip to main content

Table 2 Fasting lipids and apolipoproteins 1

From: Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins

Variable

African-Americans (n = 14)

Whites (n = 18)

P-Value2

Cholesterol (mg/dL)

185 ± 41

172 ± 35

0.20

TG (mg/dL)

79 ± 45

98 ± 50

0.15

HDL cholestrol (mg/dL)

56 ± 14

49 ± 11

0.10

LDL cholesterol (mg/dL)

113 ± 34

102 ± 29

0.23

ApoAI (mg/dL)

175 ± 32

167 ± 30

0.52

Apo AI of HDL with ApoC-III (mg/dL)

13.2 ± 3.0

12.7 ± 2.6

0.57

Apo AI of HDL without ApoC-III (mg/dL)

162 ± 30

154 ± 28

0.52

ApoCIII (mg/dL)

10.4 ± 3.7

9.6 ± 3.9

0.55

HDL-ApoCIII (mg/dL)

7.0 ± 2.9

5.7 ± 3.1

0.23

Light VLDL-ApoCIII (mg/dL)

1.5 ± 1.4

1.7 ± 1.1

0.60

Dense VLDL-ApoCIII (mg/dL)

0.61 ± 0.55

0.93 ± 0.51

0.10

IDL-ApoCIII (mg/dL)

0.28 ± 0.29

0.32 ± 0.28

0.68

LDL-ApoCIII (mg/dL)

1.0 ± 0.6

1.0 ± 0.5

0.68

  1. 1Data presented as mean ± SD.
  2. 2Comparisons by unpaired t-tests.